Forschung
Lehre
Lösungen
Anmelden
DE
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Tianjin Institute of Urology
Hui Xie has not added Biography.
If you are Hui Xie and would like to personalize this page please email our Author Liaison for assistance.
C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Clinica chimica acta; international journal of clinical chemistry Dec, 2017 | Pubmed ID: 29080691
Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals.
Cancer management and research , 2017 | Pubmed ID: 29200888
Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis.
Oncotarget Nov, 2017 | Pubmed ID: 29254251
Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals.
Clinical and experimental medicine May, 2018 | Pubmed ID: 29362922
Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Clinica chimica acta; international journal of clinical chemistry May, 2018 | Pubmed ID: 29462592
Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma.
Clinica chimica acta; international journal of clinical chemistry Nov, 2018 | Pubmed ID: 30006290
Neutrophil-lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis.
Cancer management and research , 2018 | Pubmed ID: 30271208
High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients.
Medical science monitor : international medical journal of experimental and clinical research Nov, 2018 | Pubmed ID: 30427826
Correction: Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis.
Oncotarget 11, 2018 | Pubmed ID: 30555638
Development and validation of CT imaging-based preoperative nomogram in the prediction of unfavorable high-grade small renal masses.
Cancer management and research , 2019 | Pubmed ID: 31576175
Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer.
Vaccines Jul, 2021 | Pubmed ID: 34358202
Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer.
Frontiers in genetics , 2022 | Pubmed ID: 35559045
The Second Hospital of Tianjin Medical University
Huiqin Tang*,1,
Hui Xie*,1,
Zhun Wang1,
Shuanghe Peng2,
Wenli Ni1,
Linpei Guo3
1Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University,
2Department of Pathology, The Second Hospital of Tianjin Medical University,
3Department of Urology, The Affiliated Wuxi No.2 People’s Hospital of Nanjing Medical University
Datenschutz
Nutzungsbedingungen
Richtlinien
Kontakt
BIBLIOTHEKS-EMPFEHLUNG
JoVE-Newsletter
JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Ressourcen für Lehrende
Autoren
Bibliothekare
Zugang
ÜBER JoVE
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten
